COMPASS THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
COMPASS THERAPEUTICS, INC. (CMPX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $708.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $355.00K, a 32.96% increase year-over-year.
- COMPASS THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $353.00K, a 57.59% increase year-over-year.
- COMPASS THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $353.00K, a 61.19% increase year-over-year.
- COMPASS THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $352.00K, a 9.32% increase year-over-year.
- COMPASS THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $1.20M, a 2.75% increase from fiscal 2024.
- COMPASS THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $1.16M, a 2.27% decline from fiscal 2023.
- COMPASS THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $1.19M, a 6.15% increase from fiscal 2022.
- COMPASS THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $1.12M, a 6.05% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $355.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $708.00K 10-Q · filed 2026-08-06 | $1.06M derived: sum of 3 quarters · filed 2026-08-06 | $1.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $353.00K 10-Q · filed 2026-05-05 | $706.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.06M derived: sum of 3 quarters · filed 2026-05-05 | $1.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $353.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $705.00K derived: sum of 2 quarters · filed 2026-03-05 | $972.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.20M 10-K · filed 2026-03-05 |
| 2025-09-30 | $352.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $619.00K derived: sum of 2 quarters · filed 2026-08-06 | $843.00K 10-Q · filed 2025-11-05 | $1.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $491.00K 10-Q · filed 2026-08-06 | $710.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $224.00K 10-Q · filed 2026-05-05 | $443.00K derived: sum of 2 quarters · filed 2026-05-05 | $765.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.08M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $541.00K derived: sum of 2 quarters · filed 2026-03-05 | $855.00K derived: sum of 3 quarters · filed 2026-03-05 | $1.16M 10-K · filed 2026-03-05 |
| 2024-09-30 | $322.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $636.00K derived: sum of 2 quarters · filed 2025-11-05 | $945.00K 10-Q · filed 2025-11-05 | $1.25M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $314.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $623.00K 10-Q · filed 2025-08-11 | $930.00K derived: sum of 3 quarters · filed 2025-08-11 | $1.23M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $309.00K 10-Q · filed 2025-05-08 | $616.00K derived: sum of 2 quarters · filed 2025-05-08 | $918.00K derived: sum of 3 quarters · filed 2025-05-08 | $1.21M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $609.00K derived: sum of 2 quarters · filed 2025-02-27 | $904.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.19M 10-K · filed 2025-02-27 |
| 2023-09-30 | $302.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $597.00K derived: sum of 2 quarters · filed 2024-11-12 | $884.00K 10-Q · filed 2024-11-12 | $1.17M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $295.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $582.00K 10-Q · filed 2024-08-12 | $871.00K derived: sum of 3 quarters · filed 2024-08-12 | $1.16M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $287.00K 10-Q · filed 2024-05-13 | $576.00K derived: sum of 2 quarters · filed 2024-05-13 | $861.00K derived: sum of 3 quarters · filed 2024-05-13 | $1.14M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $574.00K derived: sum of 2 quarters · filed 2024-03-21 | $852.00K derived: sum of 3 quarters · filed 2024-03-21 | $1.12M 10-K · filed 2024-03-21 |
| 2022-09-30 | $285.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $563.00K derived: sum of 2 quarters · filed 2023-11-09 | $833.00K 10-Q · filed 2023-11-09 | $1.10M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $278.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $548.00K 10-Q · filed 2023-08-03 | $820.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.09M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $270.00K 10-Q · filed 2023-05-04 | $542.00K derived: sum of 2 quarters · filed 2023-05-04 | $810.00K derived: sum of 3 quarters · filed 2023-05-04 | $1.07M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $540.00K derived: sum of 2 quarters · filed 2023-03-15 | $802.00K derived: sum of 3 quarters · filed 2023-03-15 | $1.06M 10-K · filed 2023-03-15 |
| 2021-09-30 | $268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $530.00K derived: sum of 2 quarters · filed 2022-11-09 | $786.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $262.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $518.00K 10-Q · filed 2021-08-16 | ||
| 2021-06-20 | $262.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $518.00K 10-Q · filed 2022-08-01 | $518.00K derived: sum of 3 quarters · filed 2022-08-01 | $518.00K derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $256.00K 10-Q · filed 2022-05-09 | $256.00K derived: sum of 2 quarters · filed 2022-05-09 | $256.00K derived: sum of 3 quarters · filed 2022-05-09 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $0.00 derived: sum of 2 quarters · filed 2022-03-18 | $0.00 10-K · filed 2022-03-18 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |